Annovis Bio, Inc. (ANVS)

USD 1.61

(2.55%)

Total Assets Summary of Annovis Bio, Inc.

Annovis Bio, Inc.'s latest annual total assets in 2023 was 10.2 Million USD , down -71.66% from previous year.
Annovis Bio, Inc.'s latest quarterly total assets in 2024 Q2 was 5.04 Million USD , down -35.41% from previous quarter.
Annovis Bio, Inc. reported annual total assets of 36.02 Million USD in 2022, down -21.69% from previous year.
Annovis Bio, Inc. reported annual total assets of 46 Million USD in 2021, up 466.57% from previous year.
Annovis Bio, Inc. reported quarterly total assets of 7.81 Million USD for 2024 Q1, down -23.46% from previous quarter.
Annovis Bio, Inc. reported quarterly total assets of 10.2 Million USD for 2023 Q4, down -0.15% from previous quarter.

Annual Total Assets Chart of Annovis Bio, Inc. (2023 - 2017)

Historical Annual Total Assets of Annovis Bio, Inc. (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	10.2 Million USD	-71.66%
2022	36.02 Million USD	-21.69%
2021	46 Million USD	466.57%
2020	8.11 Million USD	626.82%
2019	1.11 Million USD	2090.75%
2018	50.99 Thousand USD	-85.75%
2017	357.96 Thousand USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	5.04 Million USD	-35.41%
2024 Q1	7.81 Million USD	-23.46%
2023 Q4	10.2 Million USD	-0.15%
2023 Q2	22.81 Million USD	-10.69%
2023 FY	10.2 Million USD	-71.66%
2023 Q1	25.54 Million USD	-29.08%
2023 Q3	10.22 Million USD	-55.19%
2022 Q3	32.48 Million USD	-11.06%
2022 Q1	43.29 Million USD	-5.88%
2022 FY	36.02 Million USD	-21.69%
2022 Q4	36.02 Million USD	10.88%
2022 Q2	36.52 Million USD	-15.64%
2021 Q4	46 Million USD	-3.46%
2021 Q2	49.49 Million USD	729.78%
2021 FY	46 Million USD	466.57%
2021 Q1	5.96 Million USD	-26.53%
2021 Q3	47.65 Million USD	-3.73%
2020 Q1	11.44 Million USD	924.18%
2020 Q3	9.4 Million USD	-7.83%
2020 Q4	8.11 Million USD	-13.64%
2020 FY	8.11 Million USD	626.82%
2020 Q2	10.2 Million USD	-10.84%
2019 Q1	431.26 Thousand USD	745.75%
2019 Q2	300.45 Thousand USD	-30.33%
2019 Q3	379.87 Thousand USD	26.43%
2019 Q4	1.11 Million USD	194.07%
2019 FY	1.11 Million USD	2090.75%
2018 Q1	- USD	0.0%
2018 FY	50.99 Thousand USD	-85.75%
2018 Q4	50.99 Thousand USD	0.0%
2017 FY	357.96 Thousand USD	0.0%

Peer Total Assets Comparison of Annovis Bio, Inc.

Name	Total Assets	Total Assets Difference
ADC Therapeutics SA	354.78 Million USD	97.123%
Alto Neuroscience, Inc.	86.62 Million USD	88.216%
Biohaven Pharmaceutical Holding Company Ltd.	513.21 Million USD	98.011%
Ginkgo Bioworks Holdings, Inc.	1.66 Billion USD	99.387%
Nuvation Bio Inc.	621.48 Million USD	98.357%
Nuvation Bio Inc.	621.48 Million USD	98.357%
Arcus Biosciences, Inc.	1.09 Billion USD	99.068%
Zymeworks Inc.	580.88 Million USD	98.243%